查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2095574

Johne氏病診斷市場－2026-2032年全球市場預測

Johne's Disease Diagnostics Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，Johne氏病診斷市場將成長至 11.6411 億美元，複合年成長率為 7.45%。

主要市場統計數據
基準年 2025 7.0371億美元
預計年份：2026年 7.5304億美元
預測年份：2032年 1,164,110,000 美元
複合年成長率 (%) 7.45%

Johne氏病的診斷在畜牧業健康管理中發揮核心作用，酪農和牛養殖戶、獸醫、實驗室和動物衛生部門都在努力控制副結核分枝桿菌（MAP），即約翰氏症（也稱為副結核病）的病原體。由於疾病具有慢性進行性，一旦在牛群中定植便難以根除，因此早期檢測、風險監測和長期牛群管理至關重要。診斷流程通常結合酵素免疫分析法（ELISA）、糞便培養、聚合酵素鏈鎖反應（PCR）、環境採樣和確診試驗，以識別感染動物並控制透過糞便、初乳、牛奶和受污染的產犢環境傳播的感染。可靠的約翰氏症檢測需求源自於其造成的經濟負擔，包括牛奶產量下降、過早淘汰、繁殖力降低和動物福利惡化。由於副結核分枝桿菌（MAP）感染可無症狀持續多年，因此診斷必須權衡敏感性、特異性、採樣頻率、畜群流行率和感染階段。因此，最有效的診斷策略並非單一檢測，而是將檢測結果與生物安全、牛管理、糞便管理、風險分級和獸醫解讀相結合的綜合檢測方案。隨著食品供應鏈中可追溯性、合理使用抗生素、動物福利和預防性牛健康管理的重要性日益凸顯，Johne氏病的診斷正從被動的疾病確認轉變為主動的牛層面管理和保障。

Johne氏病診斷領域的變革性變化

Johne氏病的診斷格局正從偶爾的個體檢測轉向數據驅動的、持續的群體監測。雖然傳統的糞便培養因其特異性仍然重要，但副結核分枝桿菌（MAP）是一種生長緩慢的微生物，因此檢測耗時較長。另一方面，聚合酶鍊式反應（PCR）可以更快地檢測到MAP DNA，從而支持更及時地做出關於隔離、撲殺或控制隔離的決策。酵素連結免疫吸附試驗（ELISA）因其可擴展性和實用性，在群體篩檢中繼續發揮至關重要的作用，尤其是在結合臨床病史和重複檢測結果進行解讀時。環境採樣對於檢測群體層面的病原體排泄模式變得越來越重要，尤其是在大規模酪農，因為個別採樣需要大量資源。一個重要的轉變是向基於風險的檢測方案過渡，該方案優先考慮高風險年齡層、臨床疑似個體、外購動物以及已知感染途徑的群體。實驗室也在改進檢體物流、數位化報告、品質保證和決策支援輸出，以使獸醫能夠將檢測結果轉化為可操作的應對方案。另一個顯著的變化是診斷技術與農場認證、自願管理計畫和本地監測系統的整合日益加深。隨著生產者努力減少慢性病造成的損失並提高牛的抵抗力，約翰氏症檢測正從一次性診斷手段發展成為預防性獸醫服務的重要組成部分。

人工智慧對約翰氏症檢測的累積影響

人工智慧正開始影響Johne氏病的診斷，其角色並非取代現有的檢查室方法，而是改善對複雜牛數據的解讀。人工智慧驅動的分析可以整合時間序列的ELISA結果、PCR結果、產乳量記錄、產犢數量、年齡、產犢史、動物移動數據和臨床觀察結果，從而識別需要複檢或管理干預的個體或畜群。機器學習模型可以輔助對MAP感染間歇性且無症狀的畜群進行風險分層，因為僅憑一次診斷難以發現病原體。在檢查室操作中，人工智慧可以支援工作流程最佳化、檢測測試結果異常、根據需要解讀影像和訊號以及自動品管審核。對於獸醫和生產者而言，決策支援工具可以將診斷資料轉化為可操作的建議，例如優先改善牛管理、識別高風險圈舍或最佳化檢測間隔。當模型基於檢驗的資料集進行訓練、基於透明的性能指標進行管理並與獸醫監管相結合時，人工智慧的累積效應最為顯著。鑑於 MAP 感染的生物學複雜性以及對假陽性和假陰性結果的解讀的影響，人工智慧不應被視為獨立的診斷工具，而應被視為提高監測準確性的補充手段。

Johne氏病診斷的關鍵區域性見解

在亞太地區，Johne氏病的診斷受到快速現代化酪農系統、混合畜群結構和多樣化生產環境等因素的影響，因此需要加強檢測能力。在酪農和肉牛生產集約化國家，PCR、ELISA 和畜群篩檢對於確保生物安全和提高生產力至關重要。同時，在以小規模農戶為主的地區，則需要經濟高效的採樣策略和更強力的獸醫支援。在歐洲，重點仍然是動物福利、食品鏈保障和協調的疾病管理，許多國家在獸醫監督下採用牛分類、標靶檢測和管理策略。歐洲的診斷格局也受到嚴格的檢查室標準、可追溯性要求以及跨境牲畜貿易相關因素的影響。北美是Johne氏病氏症診斷最發達的地區之一，這得益於完善的獸醫檢查室網路、自願性牛管理計劃、酪農牛健康諮詢以及 ELISA、糞便 PCR 和環境檢測的廣泛應用。在該地區，系統性的副結核分枝桿菌（MAP）監測以預防性牛健康管理、牛奶品質和牲畜流動可追溯性為重點。拉丁美洲的診斷情況各不相同，巴西和墨西哥由於其龐大的牛數量以及不斷擴大的乳牛和肉牛生產，產生了巨大的需求。實施情況與獸醫服務的可及性、生產者的意識以及將MAP檢測納入更廣泛的感染疾病控制措施的能力密切相關。在非洲，診斷情況更為分散，需求與酪農發展計畫、進口牛的遺傳資源以及加強對慢性牲畜疾病監測的需求有關。每個地區的進展都取決於檢測設施的基礎設施、成本效益、檢體運輸系統以及將Johne氏病診斷納入更廣泛的獸醫公共衛生和生產衛生計劃的能力。在中東，由於酪農集約化、進口種牛和對高價值牛的投資，生物安全篩檢的重要性日益凸顯，Johne氏病診斷也因此受到越來越多的關注。檢測的實施通常集中在商業農場和政府支持的動物健康舉措。

Johne氏病診斷的主要群體分析

在北約成員國（其中許多與北美和歐洲的畜牧業已開發經濟體重疊），健全的生物安全體系、協調的獸醫系統和完善的診斷實驗室網路有利於Johne氏病的診斷。七國集團（G7）國家通常擁有先進的診斷能力、嚴格的檢查室認證制度以及廣泛的獸醫專業知識，從而能夠建立結合血清學檢測、分子檢測、Johne氏病採樣和畜群風險評估的高水平監測模式。金磚國家擁有世界上規模最大的畜牧人口和多樣化的生產系統，在維持生產力、進行遺傳改良計畫和確保畜群長期韌性方面發揮著至關重要的作用。在這些國家，診斷技術的應用與可擴展的檢測模式、獸醫基礎設施以及乳牛和肉牛價值鏈的現代化密切相關。歐盟透過統一的動物健康原則、品管的檢測實驗室以及對動物福利和食品系統透明度的高度重視，支持建立更系統性的副結核分枝桿菌（MAP）診斷環境。歐盟層級的貿易整合也提升了可靠的跨境檢測記錄的重要性。在東協地區，小規模酪農、商業性畜牧養殖場以及不斷擴展的獸醫檢測實驗室網路並存，這影響著Johne氏病的診斷。該地區的實際檢測策略傾向於優先考慮經濟實惠的篩檢、生產者教育以及與更廣泛的牛健康管理計劃的整合。在海灣合作理事會（GCC）地區，疾病預防和入境篩檢是約翰氏症檢測的關鍵篩檢，尤其是在那些由於高價值酪農系統、溫控生產設施以及對進口遺傳資源的依賴而將牛生物安全作為戰略重點的地區。這些地區的通用趨勢是從孤立的檢測轉向綜合性的MAP（肺炎支原體）控制計劃，該計劃將診斷與動物流動管理、牛衛生管理、糞便管理和生產者決策支持聯繫起來。

主要國家Johne氏病診斷趨勢

在中國，隨著畜牧業產業化的發展，動物健康診斷水準不斷提高，約翰氏症檢測在大規模酪農、牛擴張計畫以及進口遺傳資源管理中日益重要。在美國，Johne氏病的診斷體系較為成熟，這得益於廣泛的獸醫實驗室、完善的乳牛群健康管理計劃，以及在基於風險的應對方案中普遍應用酶聯免疫吸附試驗（ELISA）、糞便PCR和環境採樣等檢測方法。日本擁有高生物安全標準、先進的檢測系統和集約化的畜牧管理模式，這些都為在牛健康管理計劃中應用精準診斷提供了支持。印度擁有世界上規模最大的牛和水牛群之一，由於農場規模的多樣性、獸醫保健系統的區域差異以及對可擴展且價格合理的篩檢檢測的需求，面臨著複雜的診斷挑戰。德國憑藉其先進的檢測能力和深厚的酪農傳統，正日益將診斷與動物福利、農場品質保證和生物安全計畫結合。在英國，獸醫主導的疾病控制、品質保證和牛健康規劃備受重視，約翰氏症檢測已成為酪農管理的重要工具。澳洲受益於健全的獸醫監測體系、以出口為導向的畜牧標準和完善的生物安全措施，使Johne氏病診斷成為疾病風險管理和牛保障這一更廣泛框架的一部分。法國、義大利和西班牙擁有完善的檢查室和大規模的酪農及反芻動物生產，在這些國家，副結核分枝桿菌（MAP）檢測有助於牛分類、動物福利目標的實現以及預防性獸醫服務。在韓國，集約化畜牧系統、高可追溯性要求和先進的檢測能力支持在以生物安全為重點的牛健康計畫中精準應用Johne氏病診斷。在加拿大，強力的獸醫監管、生產者教育以及對酪農和牛畜群生物安全的重視，加上檢測的普及和疾病控制意識的提高，牛為診斷的應用提供了支持。在俄羅斯，廣闊的地域和多樣化的生產體系導致診斷服務的可及性存在差異，但大規模酪農的現代化推動了對系統性疾病監測的需求。巴西的大規模酪農和牛產業對副結核分枝桿菌（MAP）的監測至關重要，尤其是在旨在提高繁殖性能、產奶量和牛壽命的商業牛中。在墨西哥，大規模畜牧業和對生產力日益成長的重視促進了診斷技術的應用，儘管不同地區和生產規模的畜牧業可及性可能存在差異。

為行業領導者提供的實用建議

產業領導者應優先考慮整合ELISA、PCR、環境採樣和獸醫風險評估的綜合診斷方案，而非依賴單一檢測結果。診斷服務提供者和實驗室應加強對檢測驗證、週轉時間、檢體可追溯性、數位化報告和結果解讀的指導，以幫助生產者及時做出牛管理決策。獸醫服務機構應擴大對生產者的教育，使其了解副結核分枝桿菌（MAP）傳播的相關風險，特別是牛暴露、糞便污染、初乳管理以及補充牲畜的購買。畜牧經營者應實施重複檢測，隔離高風險動物，改善產犢欄的衛生狀況，避免餵食來自不明來源牛的混合初乳，並根據獸醫的解讀做出淘汰決定。政策制定者和動物衛生部門可以透過支援自願控制方案、檢查室品質標準、協調監測以及為中小農場提供便捷的檢測系統來改善結果。技術開發人員應專注於開發決策支援平台，將診斷結果與農場記錄整合，同時保持透明度、資料安全性和獸醫課責。在整個價值鏈中，最有效的策略是將Johne氏病診斷作為持續管理系統的一部分，該系統將檢測頻率、生物安全、牲畜流動和長期畜群改良聯繫起來。

調查方法

本執行摘要採用系統化的二手調查方法編寫，重點關注獸醫學、動物健康、診斷和畜牧管理方面的檢驗資訊來源。該方法包括對副結核分枝桿菌（MAP）、診斷測試表現、MAP傳播和畜群管理策略的同行評審科學文獻進行回顧。此外，也參考了獸醫權威機構、農業推廣計畫、動物衛生機構和檢查室提供的最佳實踐參考資料，以及疾病控制框架發布的指南。摘要整合了各種診斷方法，包括酵素連結免疫吸附試驗（ELISA）、糞便培養、聚合酶鍊式反應（PCR）、環境採樣和畜群層面的監測模型。區域、群體和國家層面的觀點源自於畜牧生產系統、獸醫基礎設施、實驗室能力、生物安全措施和動物衛生管治的差異。本調查方法不涉及市場規模估算、預測和競爭佔有率分析；而是專注於基於證據的行業趨勢、應用促進因素、營運挑戰以及對相關人員的可操作性影響。報告的研究結果證實，約翰氏症與既有認知相符，是一種慢性疾病，通常無症狀，難以根除，最有效的管理方法是結合反覆檢測、生物安全和群體控制措施。

結論

隨著畜牧業向預防性健康管理、可追溯性和數據驅動的生物安全轉型，Johne氏病的診斷正進入一個更具策略性的階段。由於副結核分枝桿菌（MAP）感染可在臨床症狀出現前長期潛伏，並可在畜群環境中傳播，因此診斷的價值取決於重複監測、選擇合適的檢測方法以及獸醫的解釋。酵素連結免疫吸附試驗（ELISA）、聚合酶鍊式反應（PCR）、培養和環境採樣各自發揮不同的作用，而最完善的防治方案會將這些工具與牛衛生、糞便管理、動物流動管理和生產者教育結合。儘管區域實施情況因實驗室能力、畜群結構、商業化程度和政策支持而異，但全球發展方向是明確的：約翰氏症檢測正變得更加一體化、數位化和基於風險。人工智慧和先進的分析技術，結合檢驗的檢測結果和負責任的獸醫決策，可以進一步加強監測。行業領導者的機會在於建立一個易於獲取、可靠且可操作的診斷生態系統，從而減少慢性疾病造成的損失，改善動物福利，並支持永續的畜牧業生產力，而無需過度依賴一次性測試或檢驗的假設。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章Johne氏病診斷市場：依動物類型分類

  • 牛
    • 肉牛
    • 乳牛
  • 綿羊和山羊

第8章Johne氏病診斷市場：依檢測類型分類

  • 培養方法
    • 液體培養基
    • 固體培養基培養
  • ELISA
  • PCR
  • 基於序列的檢測
    • 目標序列面板
    • 全基因組定序

第9章Johne氏病診斷市場：依檢體類型分類

  • 糞便檢體
  • 牛奶檢體
  • 組織檢體

第10章Johne氏病診斷市場：依最終用戶分類

  • 診斷實驗室
    • 醫院檢查室
    • 獨立檢測實驗室
  • 農場
    • 種子農場
    • 酪農
  • 研究機構
  • 動物診所

第11章Johne氏病診斷市場：依通路分類

  • 離線
  • 線上

第12章Johne氏病診斷市場：按地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第13章Johne氏病診斷市場：依組別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第14章Johne氏病診斷市場：依國家分類

  • 中國
  • 美國
  • 日本
  • 印度
  • 德國
  • 英國
  • 澳洲
  • 法國
  • 韓國
  • 義大利
  • 加拿大
  • 俄羅斯
  • 巴西
  • 墨西哥
  • 西班牙

第15章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abcam plc
  • Agrolabo SpA
  • BBI Solutions OEM Ltd.
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • BioNote, Inc.
  • Biopanda Reagents Ltd.
  • Cusabio Technology LLC
  • DNA Diagnostic A/S
  • Enzo Biochem, Inc.
  • FineTest BIoTech Co., Ltd.
  • Gold Standard Diagnostics Budapest Kft.
  • HiMedia Laboratories Pvt. Ltd.
  • IDEXX Laboratories, Inc.
  • INDICAL BIOSCIENCE GmbH
  • Innovative Diagnostics SAS
  • LGC Clinical Diagnostics, Inc.
  • MV Diagnostics Ltd.
  • MyBioSource, Inc.
  • Neogen Corporation
  • PBD BIoTech Ltd.
  • Pictor Diagnostics Ltd.
  • Promega Corporation
  • QIAGEN NV
  • Randox Laboratories Ltd.
  • RayBIoTech, Inc.
  • Tetracore, Inc.
  • Thermo Fisher Scientific Inc.
  • VMRD, Inc.
  • Zoetis Inc.
Product Code: MRR-0D217D5AD843

The Johne's Disease Diagnostics Market is projected to grow by USD 1,164.11 million at a CAGR of 7.45% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 703.71 million
Estimated Year [2026] USD 753.04 million
Forecast Year [2032] USD 1,164.11 million
CAGR (%) 7.45%

Johne's disease diagnostics are becoming central to livestock health management as dairy and beef producers, veterinarians, laboratories, and animal health authorities work to control Mycobacterium avium subspecies paratuberculosis (MAP), the causative agent of Johne's disease, also known as paratuberculosis. The disease is chronic, progressive, and difficult to eradicate once established in a herd, making early detection, risk-based surveillance, and long-term herd management essential. Diagnostic workflows commonly combine enzyme-linked immunosorbent assay (ELISA), fecal culture, polymerase chain reaction (PCR), environmental sampling, and confirmatory testing to identify infected animals and reduce transmission through manure, colostrum, milk, and contaminated calving environments. Demand for reliable Johne's disease testing is supported by the documented economic burden of reduced milk production, premature culling, lower fertility performance, and compromised animal welfare. Because MAP infection may remain subclinical for years, diagnostics must balance sensitivity, specificity, sampling frequency, herd prevalence, and stage of infection. The strongest diagnostic strategies are therefore not isolated tests but integrated testing programs that combine laboratory evidence with biosecurity, calf management, manure control, risk classification, and veterinary interpretation. As food supply chains place greater emphasis on traceability, antimicrobial stewardship, animal welfare, and preventive herd health, Johne's disease diagnostics are evolving from reactive disease confirmation toward proactive herd-level control and assurance.

Transformative Shifts in the Johne's Disease Diagnostics Landscape

The Johne's disease diagnostics landscape is shifting from occasional animal-level testing toward continuous, data-informed herd surveillance. Traditional fecal culture remains valued for specificity but is slow because MAP is a slow-growing organism, while PCR offers faster detection of MAP DNA and supports more timely decisions on isolation, culling, or management segregation. ELISA continues to play a major role in herd screening due to scalability and practicality, especially when interpreted alongside clinical history and repeated testing. Environmental sampling is gaining relevance for detecting herd-level shedding patterns, particularly in large dairy operations where individual animal sampling can be resource intensive. A major transformation is the movement toward risk-based testing protocols that prioritize high-risk age groups, clinical suspects, purchased animals, and herds with known transmission pathways. Laboratories are also improving sample logistics, digital reporting, quality assurance, and decision-support outputs to help veterinarians translate results into actionable control plans. Another important shift is the growing alignment of diagnostics with farm certification, voluntary control programs, and regional surveillance frameworks. As producers seek to reduce chronic disease losses and improve herd resilience, Johne's disease testing is becoming an embedded component of preventive veterinary services rather than a one-time diagnostic event.

Cumulative Impact of Artificial Intelligence on Johne's Disease Testing

Artificial intelligence is beginning to influence Johne's disease diagnostics by improving how complex herd data are interpreted rather than by replacing established laboratory methods. AI-enabled analytics can combine longitudinal ELISA results, PCR outcomes, milk production records, parity, age, calving history, animal movement data, and clinical observations to flag animals or groups that warrant retesting or management intervention. Machine learning models can support risk stratification in herds where MAP infection is intermittent, subclinical, and difficult to detect through a single diagnostic event. In laboratory operations, AI can assist with workflow optimization, anomaly detection in test results, image or signal interpretation where applicable, and automated quality-control review. For veterinarians and producers, decision-support tools can translate diagnostic data into practical recommendations, such as prioritizing calf management changes, identifying high-risk pens, or refining testing intervals. The cumulative impact of artificial intelligence will be strongest when models are trained on validated datasets, governed by transparent performance metrics, and integrated with veterinary oversight. Given the biological complexity of MAP infection and the consequences of false-positive or false-negative interpretation, AI should be viewed as an augmentation layer that enhances surveillance precision, not as a standalone diagnostic authority.

Key Regional Insights for Johne's Disease Diagnostics

In Asia-Pacific, Johne's disease diagnostics are shaped by rapidly modernizing dairy systems, mixed herd structures, and the need to strengthen laboratory capacity across diverse production environments. Countries with intensive dairy and beef operations are increasingly emphasizing PCR, ELISA, and herd-level screening to support biosecurity and productivity, while smallholder-dominant areas require cost-effective sampling strategies and stronger veterinary outreach. Europe maintains a strong focus on animal welfare, food chain assurance, and coordinated disease control, with many countries using herd classification, targeted testing, and veterinary-supervised control strategies. The European diagnostic landscape is also influenced by stringent laboratory standards, traceability requirements, and cross-border livestock trade considerations. North America has one of the most developed diagnostic ecosystems for Johne's disease, supported by established veterinary laboratory networks, voluntary herd control programs, dairy herd health consulting, and wide use of ELISA, fecal PCR, and environmental testing. The region's emphasis on preventive herd health, milk quality, and traceable livestock movement supports structured MAP surveillance. Latin America presents a varied diagnostic environment, with Brazil and Mexico contributing significant demand due to large cattle populations and expanding dairy and beef production. Adoption is closely tied to veterinary service access, producer awareness, and the ability to integrate MAP testing with broader infectious disease control. Africa faces a more fragmented diagnostic landscape, with demand linked to dairy development programs, imported cattle genetics, and the need to improve surveillance for chronic livestock diseases. Regional progress depends on laboratory infrastructure, affordability, sample transport systems, and integration of Johne's disease diagnostics into broader veterinary public and production health programs. In the Middle East, Johne's disease diagnostics are gaining attention where dairy intensification, imported breeding stock, and high-value herd investments increase the importance of biosecurity screening. Testing adoption is often concentrated in commercial farms and government-supported animal health initiatives.

Key Group Insights for Johne's Disease Diagnostics

Across NATO member countries, many of which overlap with advanced livestock economies in North America and Europe, Johne's disease diagnostics benefit from robust biosecurity cultures, coordinated veterinary systems, and established diagnostic laboratory networks. G7 countries generally demonstrate advanced diagnostic capacity, strong laboratory accreditation practices, and widespread access to veterinary expertise, enabling sophisticated surveillance models that combine serology, molecular testing, environmental sampling, and herd-level risk assessment. BRICS economies bring together some of the world's largest livestock populations and diverse production systems, making Johne's disease diagnostics relevant for productivity protection, genetic improvement programs, and long-term herd resilience. In these countries, diagnostic adoption is strongly connected to scalable testing models, veterinary infrastructure, and modernization of dairy and beef value chains. The European Union supports a more structured environment for MAP diagnostics through harmonized animal health principles, quality-controlled laboratories, and strong emphasis on animal welfare and food system transparency. EU-level trade integration also increases the importance of reliable testing documentation across borders. Within ASEAN, Johne's disease diagnostics are influenced by the coexistence of smallholder dairy farms, commercial livestock operations, and expanding veterinary laboratory networks. Practical testing strategies in the group tend to prioritize affordable screening, producer education, and integration with broader herd health programs. In the GCC, high-value dairy systems, climate-controlled production units, and dependence on imported genetics make disease prevention and entry screening important drivers of Johne's disease testing, particularly where herd biosecurity is a strategic priority. Across these groups, the common trend is the movement from isolated testing toward integrated MAP control programs that connect diagnostics with animal movement controls, calf hygiene, manure management, and producer decision support.

Key Country Insights for Johne's Disease Diagnostics

China is strengthening animal health diagnostics as livestock systems industrialize, with Johne's disease testing becoming more relevant in large dairy operations, herd expansion programs, and imported genetics management. The United States has a mature Johne's disease diagnostics environment supported by extensive veterinary laboratory access, dairy herd health programs, and common use of ELISA, fecal PCR, and environmental sampling in risk-based control plans. Japan is characterized by high biosecurity expectations, advanced laboratory systems, and intensive livestock management, supporting precise diagnostic use in herd health programs. India, with one of the world's largest cattle and buffalo populations, faces a complex diagnostic challenge due to diverse farm sizes, regional veterinary capacity differences, and the need for scalable, affordable screening. Germany combines advanced laboratory capacity with a strong dairy tradition, where diagnostics are increasingly aligned with animal welfare, farm assurance, and biosecurity programs. The United Kingdom emphasizes veterinary-led disease control, quality assurance, and herd health planning, making Johne's disease testing an important tool in dairy management. Australia benefits from a strong veterinary surveillance culture, export-oriented livestock standards, and established biosecurity practices, making Johne's disease diagnostics part of a broader framework for disease risk management and herd assurance. France, Italy, and Spain combine developed laboratory infrastructure with significant dairy and ruminant production, where MAP testing supports herd classification, animal welfare objectives, and preventive veterinary services. South Korea's intensive livestock systems, high traceability expectations, and advanced laboratory capabilities support targeted use of Johne's disease diagnostics in biosecurity-focused herd health programs. Canada shows strong veterinary oversight, producer education, and attention to herd biosecurity in dairy and beef systems, with diagnostic use supported by laboratory access and disease control awareness. Russia's broad geography and mixed production systems create uneven diagnostic access, but large-scale dairy modernization supports demand for structured disease monitoring. Brazil's large dairy and beef industries create significant relevance for MAP surveillance, particularly in commercial herds seeking to improve reproductive performance, milk output, and herd longevity. Mexico's diagnostic adoption is supported by its large cattle sector and growing emphasis on productivity, although access to advanced testing can vary by region and production scale.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize integrated diagnostic programs that combine ELISA, PCR, environmental sampling, and veterinary risk assessment rather than relying on a single test result. Diagnostic providers and laboratories should strengthen assay validation, turnaround time, sample traceability, digital reporting, and interpretive guidance to help producers make timely herd management decisions. Veterinary service organizations should expand producer education on MAP transmission, especially calf exposure, manure contamination, colostrum management, and risks linked to purchasing replacement animals. Livestock operators should implement repeat testing strategies, segregate high-risk animals, improve maternity pen hygiene, avoid feeding pooled colostrum from unverified cows, and align culling decisions with veterinary interpretation. Policymakers and animal health authorities can improve outcomes by supporting voluntary control programs, laboratory quality standards, surveillance coordination, and accessible testing for small and medium-sized farms. Technology developers should focus on decision-support platforms that integrate diagnostic results with farm records while maintaining transparency, data security, and veterinary accountability. Across the value chain, the most effective strategy is to treat Johne's disease diagnostics as part of a continuous control system that links testing frequency, biosecurity, animal movement, and long-term herd improvement.

Research Methodology

This executive summary is developed through a structured secondary research methodology focused on verified veterinary, animal health, diagnostic, and livestock management sources. The approach includes review of peer-reviewed scientific literature on Mycobacterium avium subspecies paratuberculosis, diagnostic test performance, MAP transmission, and herd control strategies. It also considers publicly available guidance from veterinary authorities, agricultural extension programs, animal health organizations, laboratory best-practice references, and disease control frameworks. Insights are synthesized across diagnostic modalities, including ELISA, fecal culture, PCR, environmental sampling, and herd-level surveillance models. Regional, group, and country perspectives are derived from documented differences in livestock production systems, veterinary infrastructure, laboratory capacity, biosecurity practices, and animal health governance. The methodology excludes market sizing, forecasting, and competitive share analysis, focusing instead on evidence-backed industry dynamics, adoption drivers, operational challenges, and practical implications for stakeholders. Content is validated for consistency with established knowledge that Johne's disease is chronic, often subclinical, difficult to eradicate, and best managed through repeated testing combined with biosecurity and herd management controls.

Conclusion

Johne's disease diagnostics are entering a more strategic phase as livestock industries move toward preventive health management, traceability, and data-driven biosecurity. Because MAP infection can remain hidden for long periods and spread through herd environments before clinical signs appear, diagnostic value depends on repeated surveillance, correct test selection, and veterinary interpretation. ELISA, PCR, culture, and environmental sampling each play distinct roles, and the most resilient control programs use these tools in combination with calf hygiene, manure management, animal movement controls, and producer education. Regional adoption varies according to laboratory capacity, herd structure, commercial intensity, and policy support, but the global direction is clear: Johne's disease testing is becoming more integrated, digital, and risk based. Artificial intelligence and advanced analytics can further strengthen surveillance when paired with validated laboratory results and accountable veterinary decision-making. For industry leaders, the opportunity lies in building accessible, reliable, and actionable diagnostic ecosystems that reduce chronic disease losses, improve animal welfare, and support sustainable livestock productivity without overreliance on one-time testing or unverified assumptions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Johne's Disease Diagnostics Market, by Animal Type

  • 7.1. Introduction
  • 7.2. Cattle
    • 7.2.1. Beef Cattle
    • 7.2.2. Dairy Cattle
  • 7.3. Sheep & Goats

8. Johne's Disease Diagnostics Market, by Test Type

  • 8.1. Introduction
  • 8.2. Culture
    • 8.2.1. Liquid Media Culture
    • 8.2.2. Solid Media Culture
  • 8.3. ELISA
  • 8.4. PCR
  • 8.5. Sequencing-Based Assays
    • 8.5.1. Targeted Sequencing Panels
    • 8.5.2. Whole-Genome Sequencing

9. Johne's Disease Diagnostics Market, by Sample Type

  • 9.1. Introduction
  • 9.2. Fecal Samples
  • 9.3. Milk Samples
  • 9.4. Tissue Samples

10. Johne's Disease Diagnostics Market, by End User

  • 10.1. Introduction
  • 10.2. Diagnostic Labs
    • 10.2.1. Hospital Labs
    • 10.2.2. Independent Labs
  • 10.3. Farms
    • 10.3.1. Breeding Farms
    • 10.3.2. Dairy Farms
  • 10.4. Research Institutes
  • 10.5. Veterinary Clinics

11. Johne's Disease Diagnostics Market, by Distribution Channel

  • 11.1. Introduction
  • 11.2. Offline
  • 11.3. Online

12. Johne's Disease Diagnostics Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. Europe
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Africa
  • 12.6. Middle East

13. Johne's Disease Diagnostics Market, by Group

  • 13.1. NATO
  • 13.2. G7
  • 13.3. BRICS
  • 13.4. European Union
  • 13.5. ASEAN
  • 13.6. GCC

14. Johne's Disease Diagnostics Market, by Country

  • 14.1. China
  • 14.2. United States
  • 14.3. Japan
  • 14.4. India
  • 14.5. Germany
  • 14.6. United Kingdom
  • 14.7. Australia
  • 14.8. France
  • 14.9. South Korea
  • 14.10. Italy
  • 14.11. Canada
  • 14.12. Russia
  • 14.13. Brazil
  • 14.14. Mexico
  • 14.15. Spain

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abcam plc
  • 16.2. Agrolabo S.p.A.
  • 16.3. BBI Solutions OEM Ltd.
  • 16.4. Bio-Rad Laboratories, Inc.
  • 16.5. bioMerieux SA
  • 16.6. BioNote, Inc.
  • 16.7. Biopanda Reagents Ltd.
  • 16.8. Cusabio Technology LLC
  • 16.9. DNA Diagnostic A/S
  • 16.10. Enzo Biochem, Inc.
  • 16.11. FineTest Biotech Co., Ltd.
  • 16.12. Gold Standard Diagnostics Budapest Kft.
  • 16.13. HiMedia Laboratories Pvt. Ltd.
  • 16.14. IDEXX Laboratories, Inc.
  • 16.15. INDICAL BIOSCIENCE GmbH
  • 16.16. Innovative Diagnostics SAS
  • 16.17. LGC Clinical Diagnostics, Inc.
  • 16.18. MV Diagnostics Ltd.
  • 16.19. MyBioSource, Inc.
  • 16.20. Neogen Corporation
  • 16.21. PBD Biotech Ltd.
  • 16.22. Pictor Diagnostics Ltd.
  • 16.23. Promega Corporation
  • 16.24. QIAGEN N.V.
  • 16.25. Randox Laboratories Ltd.
  • 16.26. RayBiotech, Inc.
  • 16.27. Tetracore, Inc.
  • 16.28. Thermo Fisher Scientific Inc.
  • 16.29. VMRD, Inc.
  • 16.30. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BEEF CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BEEF CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BEEF CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DAIRY CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DAIRY CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DAIRY CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SHEEP & GOATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SHEEP & GOATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SHEEP & GOATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LIQUID MEDIA CULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LIQUID MEDIA CULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LIQUID MEDIA CULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SOLID MEDIA CULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SOLID MEDIA CULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SOLID MEDIA CULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ELISA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ELISA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ELISA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SEQUENCING-BASED ASSAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SEQUENCING-BASED ASSAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SEQUENCING-BASED ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL TARGETED SEQUENCING PANELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL TARGETED SEQUENCING PANELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL TARGETED SEQUENCING PANELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL WHOLE-GENOME SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL WHOLE-GENOME SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL WHOLE-GENOME SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FECAL SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FECAL SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FECAL SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MILK SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MILK SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MILK SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL TISSUE SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL TISSUE SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL TISSUE SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DIAGNOSTIC LABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DIAGNOSTIC LABS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DIAGNOSTIC LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HOSPITAL LABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HOSPITAL LABS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HOSPITAL LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INDEPENDENT LABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INDEPENDENT LABS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INDEPENDENT LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BREEDING FARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BREEDING FARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BREEDING FARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DAIRY FARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DAIRY FARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DAIRY FARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 154. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 156. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 157. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 160. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 161. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 165. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 167. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 168. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 171. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 172. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 209. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 211. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 212. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 215. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 216. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 217. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 240. JAPAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 241. JAPAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. JAPAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 243. JAPAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. JAPAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 245. JAPAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 246. JAPAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. JAPAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. JAPAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 249. JAPAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 250. JAPAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 251. INDIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 252. INDIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. INDIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 254. INDIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. INDIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 256. INDIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 257. INDIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. INDIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 259. INDIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 260. INDIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 261. INDIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 262. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 265. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 267. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 268. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 270. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 271. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 272. GERMANY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED KINGDOM JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 284. AUSTRALIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 285. AUSTRALIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. AUSTRALIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 287. AUSTRALIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. AUSTRALIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 289. AUSTRALIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 290. AUSTRALIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. AUSTRALIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 292. AUSTRALIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 293. AUSTRALIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 294. AUSTRALIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 295. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 296. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 298. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 300. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 301. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 303. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 304. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 305. FRANCE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 306. SOUTH KOREA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 307. SOUTH KOREA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. SOUTH KOREA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 309. SOUTH KOREA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 310. SOUTH KOREA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 311. SOUTH KOREA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 312. SOUTH KOREA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 313. SOUTH KOREA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 314. SOUTH KOREA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 315. SOUTH KOREA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 316. SOUTH KOREA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 317. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 318. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 320. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 321. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 322. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 323. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 324. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 325. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 326. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 327. ITALY JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 328. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 329. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 330. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 331. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 333. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 334. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 335. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 336. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 337. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 338. CANADA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 339. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 340. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 341. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 342. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 343. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 344. RUSSIA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SE